ViGeneron

News

Germany’s ViGeneron is to advance development of its next-generation ophthalmology gene therapy pipeline after a series A financing round.

News

Bayer has joined the ranks of pharma groups planning major facility investments in the US, with a $2.2bn plan for a new production unit in Ohio.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.